Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,388,543
+$66,333 QoQ
Shares Held
6,596
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,177
of 3,140 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Radnor Capital Management, LLC holds $105,731,738 across 8 Drug Manufacturers - General names. AMGN ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
518,900 | $66,678,650 | |
| 2 | LLY |
ELI LILLY & Co
|
9,442 | $11,325,019 | |
| 3 | JNJ |
Johnson & Johnson
|
42,628 | $10,826,233 | |
| 4 | ABBV |
AbbVie Inc.
|
28,539 | $7,181,553 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
79,233 | $4,565,405 | |
| 6 | AMGN |
Amgen Inc
This page
|
6,596 | $2,388,543 | |
| 7 | PFE |
Pfizer Inc
|
77,621 | $1,869,113 | |
| 8 | NVS |
Novartis AG
|
5,725 | $897,222 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,388,543 | 6,596 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,322,210 | 6,600 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,244,037 | 6,856 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,819,907 | 6,449 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,917,893 | 6,869 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,140,036 | 6,869 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,833,602 | 7,035 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,414,963 | 7,495 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $2,198,085 | 7,035 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,978,867 | 6,960 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $2,004,619 | 6,960 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $1,854,444 | 6,900 | Shares | Sole | 2023-10-12 | |
| 2023-03-31 | $1,934,000 | 8,000 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $2,051,218 | 7,810 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $1,584,562 | 7,030 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,532,060 | 6,297 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,508,231 | 6,237 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,420,010 | 6,312 | Shares | Sole | 2022-01-20 | |
| 2021-06-30 | $537,956 | 2,207 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $549,123 | 2,207 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $507,433 | 2,207 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $554,577 | 2,182 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $469,833 | 1,992 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $403,838 | 1,992 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||